ECSP13012573A - 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3 - Google Patents
6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3Info
- Publication number
- ECSP13012573A ECSP13012573A ECSP13012573A ECSP13012573A EC SP13012573 A ECSP13012573 A EC SP13012573A EC SP13012573 A ECSP13012573 A EC SP13012573A EC SP13012573 A ECSP13012573 A EC SP13012573A
- Authority
- EC
- Ecuador
- Prior art keywords
- nicotinamides
- amino
- substituted
- kcnq2
- modulators
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Abstract
La invención se refiere a 6-amino-nicotinamidas sustituidas, para composiciones farmacéuticas que contengan estos compuestos y también para estos compuestos para uso en el tratamiento y/o profilaxis del dolor y otras patologías y/o trastornos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10013811 | 2010-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP13012573A true ECSP13012573A (es) | 2013-07-31 |
Family
ID=43447658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP13012573 ECSP13012573A (es) | 2010-10-20 | 2013-04-22 | 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3 |
Country Status (19)
Country | Link |
---|---|
US (1) | US8552200B2 (es) |
EP (2) | EP2630123B1 (es) |
JP (1) | JP5947307B2 (es) |
KR (1) | KR101820645B1 (es) |
CN (1) | CN103209962B (es) |
AR (1) | AR083477A1 (es) |
AU (1) | AU2011317855B2 (es) |
BR (1) | BR112013010957A2 (es) |
CA (1) | CA2815131C (es) |
CL (1) | CL2013001073A1 (es) |
CO (1) | CO6690805A2 (es) |
EA (1) | EA022582B1 (es) |
EC (1) | ECSP13012573A (es) |
ES (1) | ES2678899T3 (es) |
IL (1) | IL225762A (es) |
MX (1) | MX367623B (es) |
NZ (2) | NZ610689A (es) |
PE (1) | PE20140199A1 (es) |
WO (1) | WO2012052167A1 (es) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012502048A (ja) | 2008-09-08 | 2012-01-26 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法 |
US8389522B2 (en) | 2008-10-28 | 2013-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase and methods of use thereof |
US9168259B2 (en) | 2010-10-20 | 2015-10-27 | Grünenthal GmbH | Substituted 6-amino-nicotinamides as KCNQ2/3 modulators |
US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
MX2014012491A (es) | 2012-04-18 | 2014-11-14 | Grünenthal GmbH | 4-aminobenzamidas sustituidas como moduladores de kcnq2/3. |
LT2888233T (lt) * | 2012-04-18 | 2017-01-10 | Grünenthal GmbH | Pakeistieji 6-amino-nikotinamidai, turintys oh-turinčią grupę, kaip kcnq2/3 moduliatoriai |
KR20150022985A (ko) * | 2012-07-19 | 2015-03-04 | 닛뽕소다 가부시키가이샤 | 피리딘 화합물 및 농원예용 살균제 |
US9775843B2 (en) | 2012-10-11 | 2017-10-03 | Grünenthal GmbH | Treatment and/or prophylaxis of TSPO mediated diseases and/or disorders |
BR112015012418A2 (pt) | 2012-11-28 | 2017-07-11 | Gruenenthal Gmbh | carboxamidas específicas como moduladores de kcnq2/3 |
US9248122B2 (en) | 2012-11-28 | 2016-02-02 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as KCNQ2/3 modulators |
EP2925759A1 (en) * | 2012-11-28 | 2015-10-07 | Grünenthal GmbH | Heteroquinoline-3-carboxamides as kcnq2/3 modulators |
EP2925316A1 (en) * | 2012-11-28 | 2015-10-07 | Grünenthal GmbH | Substituted amino-arylcarboxamides as kcnq2/3 modulators |
JO3377B1 (ar) | 2013-03-11 | 2019-03-13 | Takeda Pharmaceuticals Co | مشتقات بيريدينيل وبيريدينيل مندمج |
JP6410790B2 (ja) | 2013-03-14 | 2018-10-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ミトコンドリアアルデヒドデヒドロゲナーゼ−2調節因子およびその使用方法 |
EP3450557A1 (en) | 2013-12-25 | 2019-03-06 | JCR Pharmaceuticals Co., Ltd. | Novel anti-transferrin receptor antibody that passes through blood-brain barrier |
CN111407726A (zh) * | 2020-04-13 | 2020-07-14 | 牡丹江医学院 | 一种治疗口腔炎的药物制剂及其制备方法 |
CN112624966B (zh) * | 2020-12-25 | 2022-12-23 | 杭州澳赛诺生物科技有限公司 | 一种2-氨甲基-4-甲基-5-吡啶羧酸的合成方法 |
EP4074317A1 (en) | 2021-04-14 | 2022-10-19 | Bayer AG | Phosphorus derivatives as novel sos1 inhibitors |
IL308349A (en) | 2021-08-10 | 2024-01-01 | Abbvie Inc | NICOTINAMIDE RIPK1 INHIBITORS |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2230392A1 (de) * | 1972-06-22 | 1974-01-31 | Cassella Farbwerke Mainkur Ag | Substituierte pyridinverbindungen und verfahren zu ihrer herstellung |
DE2513949A1 (de) * | 1975-03-29 | 1976-10-07 | Bayer Ag | Azofarbstoffe |
CA2412208C (en) * | 2000-06-29 | 2009-08-18 | Neurosearch A/S | Use of 3-substituted oxindole derivatives as kcnq potassium channel modulators |
CA2438868A1 (en) | 2001-02-20 | 2002-09-19 | Valentin K. Gribkoff | Modulators of kcnq potassium channels and use thereof in treating migraine and mechanistically related diseases |
EP1361879A1 (en) | 2001-02-20 | 2003-11-19 | Bristol-Myers Squibb Company | 2,4-disubstituted pyrimidine-5-carboxamide derivatives as kcnq potassium channel modulators |
GB0222495D0 (en) * | 2002-09-27 | 2002-11-06 | Glaxo Group Ltd | Compounds |
GB0402357D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
GB0402355D0 (en) * | 2004-02-03 | 2004-03-10 | Glaxo Group Ltd | Novel compounds |
MX2007010547A (es) * | 2005-03-03 | 2007-10-03 | Lundbeck & Co As H | Derivados de piridina sustituidos. |
CA2621854A1 (en) * | 2005-09-09 | 2007-06-14 | H. Lundbeck A/S | Pyrimidine derivatives and their use as kcnq potassium channels openers |
DE102006049452A1 (de) | 2006-10-17 | 2008-05-08 | Grünenthal GmbH | Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln |
DE102007044277A1 (de) * | 2007-09-17 | 2009-03-19 | Grünenthal GmbH | Substituierte Nicotinamid-Verbindungen und deren Verwendung in Arzneimitteln |
CA2739740A1 (en) | 2008-10-24 | 2010-04-29 | Gruenenthal Gmbh | Substituted 4,5,6,7-tetrahydrothienopyridines as kcnq2/3 modulators for treating pain, epilepsy and urinary incontinence |
WO2010094644A1 (en) * | 2009-02-17 | 2010-08-26 | Neurosearch A/S | Substituted pyridine derivatives and their medical use |
TWI475020B (zh) | 2009-03-12 | 2015-03-01 | The substituted nicotine amide as a KCNQ2 / 3 modifier | |
TW201038565A (en) * | 2009-03-12 | 2010-11-01 | Gruenenthal Gmbh | Substituted 2-mercapto-3-aminopyridines as KCNQ2/3 modulators |
-
2011
- 2011-10-19 BR BR112013010957A patent/BR112013010957A2/pt not_active IP Right Cessation
- 2011-10-19 NZ NZ610689A patent/NZ610689A/en not_active IP Right Cessation
- 2011-10-19 EP EP11778520.4A patent/EP2630123B1/en not_active Not-in-force
- 2011-10-19 EP EP17200118.2A patent/EP3318556A1/en not_active Withdrawn
- 2011-10-19 PE PE2013000887A patent/PE20140199A1/es not_active Application Discontinuation
- 2011-10-19 KR KR1020137012802A patent/KR101820645B1/ko active IP Right Grant
- 2011-10-19 EA EA201300471A patent/EA022582B1/ru not_active IP Right Cessation
- 2011-10-19 AR ARP110103861A patent/AR083477A1/es active IP Right Grant
- 2011-10-19 WO PCT/EP2011/005265 patent/WO2012052167A1/en active Application Filing
- 2011-10-19 NZ NZ628871A patent/NZ628871A/en not_active IP Right Cessation
- 2011-10-19 US US13/276,464 patent/US8552200B2/en not_active Expired - Fee Related
- 2011-10-19 CN CN201180050690.6A patent/CN103209962B/zh not_active Expired - Fee Related
- 2011-10-19 CA CA2815131A patent/CA2815131C/en not_active Expired - Fee Related
- 2011-10-19 AU AU2011317855A patent/AU2011317855B2/en not_active Ceased
- 2011-10-19 ES ES11778520.4T patent/ES2678899T3/es active Active
- 2011-10-19 MX MX2013004329A patent/MX367623B/es active IP Right Grant
- 2011-10-19 JP JP2013534196A patent/JP5947307B2/ja not_active Expired - Fee Related
-
2013
- 2013-04-15 IL IL225762A patent/IL225762A/en active IP Right Grant
- 2013-04-18 CL CL2013001073A patent/CL2013001073A1/es unknown
- 2013-04-22 CO CO13101928A patent/CO6690805A2/es unknown
- 2013-04-22 EC ECSP13012573 patent/ECSP13012573A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL225762A (en) | 2017-06-29 |
MX367623B (es) | 2019-08-29 |
EA201300471A1 (ru) | 2014-01-30 |
AR083477A1 (es) | 2013-02-27 |
ES2678899T3 (es) | 2018-08-20 |
JP2014510696A (ja) | 2014-05-01 |
AU2011317855A1 (en) | 2013-05-02 |
CA2815131C (en) | 2020-06-09 |
CO6690805A2 (es) | 2013-06-17 |
EP2630123B1 (en) | 2017-12-20 |
MX2013004329A (es) | 2013-04-29 |
US8552200B2 (en) | 2013-10-08 |
CN103209962B (zh) | 2016-03-02 |
NZ610689A (en) | 2014-08-29 |
KR101820645B1 (ko) | 2018-01-22 |
CL2013001073A1 (es) | 2013-10-11 |
CN103209962A (zh) | 2013-07-17 |
JP5947307B2 (ja) | 2016-07-06 |
BR112013010957A2 (pt) | 2016-08-30 |
AU2011317855B2 (en) | 2015-04-30 |
EP3318556A1 (en) | 2018-05-09 |
EA022582B1 (ru) | 2016-01-29 |
WO2012052167A1 (en) | 2012-04-26 |
CA2815131A1 (en) | 2012-04-26 |
US20120101079A1 (en) | 2012-04-26 |
IL225762A0 (en) | 2013-06-27 |
NZ628871A (en) | 2015-07-31 |
KR20140001904A (ko) | 2014-01-07 |
PE20140199A1 (es) | 2014-02-16 |
EP2630123A1 (en) | 2013-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP13012573A (es) | 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3 | |
ECSP13012453A (es) | 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3 | |
PH12016500105A1 (en) | Sulfonamides as modulators of sodium channels | |
PA8780201A1 (es) | Derivados de pirasol sustituidos con heteroaril utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis | |
GT201400111A (es) | Triazolopiridinas sustituidas | |
EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
UY33597A (es) | Compuestos y composiciones como inhibidores de la trk | |
BR112013004766A2 (pt) | 2-amino-quinolina-3-carboxamidas substituídas como moduladores de kcnq2/3 | |
UY33238A (es) | "Compuestos en calidad de antagonistas de bradiquinina-b1" | |
UY32937A (es) | Compuestos y composiciones como moduladores de la actividad de gpr119 | |
ECSP15007358A (es) | Pirrol carboxamidas fluorometilo sustituidas | |
UY35276A (es) | Nuevos compuestos que inhiben la actividad de Lp-PLA2 | |
GT201600027A (es) | Inhibidores de rorc2 y sus métodos de uso | |
MX2018004220A (es) | Tetrahidropiranilsulfonas sustituidas con pirazolilo. | |
ECSP13012460A (es) | 2-oxo- y 2-tioxo-dihidroquinolina-3-carboxamidas sustituidos como moduladores KCNQ2/3 | |
MX2018004217A (es) | Tetrahidropiranilsulfonas sustituidas con pirazolilo. | |
MX2014003584A (es) | Derivados de metanosulfonamida sustituidos como ligandos de receptores vaniloides. | |
MX2016007955A (es) | Pirrol carboxamidas iii fluorometil-sustituidas. | |
BR112016023926A2 (pt) | heterociclil sulfonas substituídas por aril | |
MX2013002295A (es) | 1-oxo-dihidroisoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3. | |
MX2016007956A (es) | Pirrol carboxamidas fluorometil-sustituidas como bloqueadores del canal de calcio de cav2.2. | |
UY31847A (es) | Nuevos derivados de imidazopiridinas, composiciones conteniéndolos y aplicaciones | |
MX2016007951A (es) | Pirrol carboxamidas iv fluorometil-sustituidas. | |
CY1118255T1 (el) | Υποκατεστημενα 6-αμινο-νικοτιναμιδια τα οποια φερουν μια ομαδα που περιεχει οη ως διαμορφωτες των kcnq2/3 | |
EA201492173A1 (ru) | Дронедарон для применения при лейшманиозе, в составах и комбинациях для применения при лейшманиозе |